MicroRNA-129-5p represses the growth and aggressiveness of oral squamous cell carcinoma via suppressing HMGB1.

The Kaohsiung Journal of Medical Sciences
Chun-Ping SongMing-Zhen Wang

Abstract

Recent investigations have suggested that microRNA-129-5p (miR-129-5p) is commonly dysregulated in multiple types of malignancies. Nevertheless, the roles of miR-129-5p in human oral squamous cell carcinoma (OSCC) are not well explored. Herein, we demonstrated that miR-129-5p was down-expressed in OSCC cells and tissues. Moreover, miR-129-5p overexpression restrained the growth, migration ability, and invasiveness of OSCC cells. Notably, high-mobility group box 1 protein (HMGB1) was identified as a downstream target of miR-129-5p. Additional, knockdown of HMGB1 suppressed the growth and aggressive phenotypes of human OSCC cells. Importantly, re-expression of HMGB1 impaired the inhibitory impacts of miR-129-5p on the metastasis of OSCC cells. Altogether, these results implied that miR-129-5p restrained the aggressiveness of OSCC cells through modulating HMGB1.

References

May 22, 2004·Annals of the New York Academy of Sciences·Rachel B HazanKimita Suyama
Feb 28, 2009·The International Journal of Developmental Biology·M Angela Nieto
Jul 3, 2009·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Akiko KusumeHiroki Kuniyasu
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
May 16, 2013·Biochemical and Biophysical Research Communications·Wen-yan ZhaoPeng Chen
Apr 29, 2015·Biochemical and Biophysical Research Communications·Ning MaQian Wang
Sep 24, 2015·International Journal of Molecular Sciences·Xuanbin WangFengjun Cao
Jan 1, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Jing LuoLi He
Apr 12, 2016·Cancer Biomarkers : Section a of Disease Markers·Bin-Hui XieHe-Ping Li
Oct 14, 2016·Oncology Research·Sheqing JiYawei Hua
Apr 17, 2017·Experimental Cell Research·Antonis KourtidisPanos Z Anastasiadis
Jun 18, 2017·Biochemical and Biophysical Research Communications·Zheng MaYoubin Cui
Aug 12, 2017·Oral Oncology·César RiveraAdriana Franco Paes Leme
Sep 29, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ming WangHaiYan Wang
Oct 24, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C YangJ Zheng
Feb 13, 2018·Journal of Cellular and Molecular Medicine·Yuling DiaoWenke Zhou
Jun 8, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qi LiuXiefu Zhang
Jan 13, 2019·Pathology, Research and Practice·Shaocheng WangLisong Teng
Mar 23, 2019·Archives of Medical Science : AMS·Li-Ping GuLi-Bo Qin
Jun 14, 2019·OncoTargets and Therapy·Ge GaoZhixin Wang

❮ Previous
Next ❯

Citations

Mar 13, 2021·The International Journal of Biological Markers·Shijuan MeiHaicheng Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.